I've noticed that as well. The June/July/August is always great etc. Even the March update with 10.8m group EBITDA. The total year came in at 29m, so taking out H1 of 13m and March quarter leaves just A6m made in June Quarter, yet June was great for Aristo at US1.6m? Obviously May was a dismal month and Star Vegas was very poor in the whole last 3 months.
Now this new carrot with DSV making US1.74m and Aristo making US1.5m in July on high 3%+ win rates, that's US39m property level EBITDA run rare for the year, and Aristo is on a run rate of US18m for the year, an astonishing figure for a property that's barely made US10m for several years on chronic and consistantly low win rates.
Ann: Investor Presentation (FY19 Full Year Results), page-4
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.53M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 187140 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 15000 | 1 |
View Market Depth
| Last trade - 10.13am 30/09/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable